EYEN - EYENOVIA, INC.
1.07
0.040 3.738%
Share volume: 14,708
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.04
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-12-2024 | |
| Total revenue | 4.993 K | 22.625 K | 1.625 K | |
| Cost of revenue | 4.993 K | 490.361 K | 132.522 K | |
| Gross profit | 0.000 | -467.736 K | -130.897 K | |
| inf% | 72.01% | |||
| Operating expenses | 8.267 M | 8.356 M | 7.201 M | |
| Selling general and admin | 3.835 M | 3.759 M | 3.729 M | |
| Research and development | 4.432 M | 4.597 M | 3.472 M | |
| Total expenses | 10.267 M | 11.221 M | 7.201 M | |
| 9.29% | -35.82% | |||
| Operating income | -10.267 M | -11.688 M | -7.332 M | |
| Ebit | -10.364 M | -10.445 M | -7.331 M | |
| Pretax income | -10.922 M | -11.054 M | -7.888 M | |
| 1.20% | -28.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -10.922 M | -11.054 M | -7.888 M | |
| -1.20% | 28.64% |
